Aspreva Announces Completion of Patient Enrolment in Phase III Clinical Trial for CellCept in Myasthenia Gravis
29th Nov 2005, 01:15 GMT
Aspreva Pharmaceuticals Corp, an emerging pharmaceutical company focused on increasing the pool of evidence-based medicines available for patients living with less common diseases, announced completion of enrolment of 176 patients in the phase III clinical study to assess the safety and efficacy of mycophenolate mofetil (MMF or CellCept ) to maintain or improve symptom control with reduced corticosteroids in patients with myasthenia gravis.
Aspreva Announces Completion of Patient Enrolment in Phase III Clinical Trial for CellCept in Myasthenia Gravis related news:
- Aspreva Announces Completion of Patient Enrolment in Phase III Clinical Trial for CellCept in Myasthenia Gravis — PR Newswire: All Releases
- Aspreva begins phase III trial in rare neuromuscular disease — Pharmaceutical Business Review Online
- Positive phase III trial for InSite eye antibiotic — Pharmaceutical Business Review Online
- BiovaxID Vaccine Therapy Of Follicular Lymphoma In First Remission, Ongoing Phase III Trial Update — Medical News Today RSS/XML Feed
- Sangamo BioSciences Completes Enrollment and Treatment in Phase 1 Clinical Trial of ZFP Therapeutic in Diabetic Neuropathy — Nephrology/ Dialysis News from StratCenter.com
- Provectus Begins Phase 1 Breast Cancer Trial — Surgery News from StratCenter.com
- InSite Vision Announces Positive Top-Line Results From First of Two Pivotal Phase 3 Clinical Trials; Pivotal Trial Succeeds in Reaching Primary Efficacy Endpoint of Clinical Resolution — RedOrbit News - Health
- Biovest Int'l Will Report New Follow-up Data from Its Phase 2 Clinical Trial of BiovaxID at the Annual Meeting of the American Society for Hematology — StratWire - Business of Healthcare NewsFeed
- Provectus initiates phase I trial in breast cancer — Pharmaceutical Business Review Online
- Accentia Biopharmaceuticals Announces That Follow-up Data from the Phase II Clinical Trial of BiovaxID Will Be Presented at the Annual Meeting of the American Society for Hematology — StratWire - Business of Healthcare NewsFeed
Latest news from StratWire - Business of Healthcare NewsFeed:
- Alliance Names New COO
- NHCAA to Award Those Who Fight and Expose the Deadly Side of Health Care Fraud
- More Than 2 mln Cancer Patients Treated with BrainLAB m3 Shaped Beam Radiosurgery
- PA's Continuing Trend Towards Total Body Reconstruction Keeps Consumers Demanding Comprehensive Direct-To-Consumer-Education (DTCE )
- Dr Farzad Yaghouti of Global Laser Vision San Diego Wins 'Best Lasik Surgeon 2006'
- 1st Study to Evaluate WelChol/Ezetimibe and Simvastatin Effect on LDL-C Finds Additional Lipid Parameter Benefits
- Medical Mutual of OH Financial Investigator Wins Top Nat'l Fraud-Fighting Award
- Intelligent Medical Objects and Bond Technologies Sign Multi-year Agreement
- M-CARE's Medicaid Plan Recognized as One of the Top Health Plans by US News & World Report/NCQA
- Fitch: MCH rates 'A-' on bonds